These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 30445229)

  • 1. Reducing the Radiation Therapy Dose Prescription for Elective Treatment Areas in Human Papillomavirus-Associated Oropharyngeal Carcinoma Being Treated With Primary Chemoradiotherapy at Memorial Sloan Kettering Cancer Center.
    Tsai CJ; McBride SM; Riaz N; Lee NY
    Pract Radiat Oncol; 2019 Mar; 9(2):98-101. PubMed ID: 30445229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Confirmation of the eighth edition of the AJCC/UICC TNM staging system for HPV-mediated oropharyngeal cancer in Japan.
    Mizumachi T; Homma A; Sakashita T; Kano S; Hatakeyama H; Fukuda S
    Int J Clin Oncol; 2017 Aug; 22(4):682-689. PubMed ID: 28271391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-category remains an important prognostic factor for oropharyngeal carcinoma in the era of human papillomavirus.
    Mackenzie P; Pryor D; Burmeister E; Foote M; Panizza B; Burmeister B; Porceddu S
    Clin Oncol (R Coll Radiol); 2014 Oct; 26(10):643-7. PubMed ID: 25001635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
    Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
    Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of radiographically occult nodal metastases in HPV+ oropharyngeal carcinoma: Implications for reducing elective nodal coverage.
    Loganadane G; Kelly JR; Lee NC; Kann BH; Mahajan A; Hansen JE; Belkacémi Y; Yarbrough W; Husain ZA
    Pract Radiat Oncol; 2018; 8(6):397-403. PubMed ID: 29730282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p16 Expression as a predictive biomarker of hypoxic cell-sensitizing agents in oropharyngeal cancer.
    Chung CH; Raben D
    J Clin Oncol; 2010 Sep; 28(27):4103-4. PubMed ID: 20697096
    [No Abstract]   [Full Text] [Related]  

  • 7. Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab.
    Rosenthal DI; Harari PM; Giralt J; Bell D; Raben D; Liu J; Schulten J; Ang KK; Bonner JA
    J Clin Oncol; 2016 Apr; 34(12):1300-8. PubMed ID: 26712222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase 2 study of docetaxel, cisplatin, and concurrent radiation for technically resectable stage III-IV squamous cell carcinoma of the head and neck.
    Inohara H; Takenaka Y; Yoshii T; Nakahara S; Yamamoto Y; Tomiyama Y; Seo Y; Isohashi F; Suzuki O; Yoshioka Y; Sumida I; Ogawa K
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):934-41. PubMed ID: 25832686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-Catenin Expression in Oropharyngeal Squamous Cell Carcinomas: Comparison and Correlation with p16 and Human Papillomavirus in situ Hybridization.
    Nwanze J; Cohen C; Schmitt AC; Siddiqui MT
    Acta Cytol; 2015; 59(6):479-84. PubMed ID: 26849661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. National patterns of care and predictors of neoadjuvant and concurrent chemotherapy use with definitive radiotherapy in the treatment of patients with oropharyngeal squamous cell carcinoma.
    Sher DJ; Rusthoven CG; Khan SA; Fidler MJ; Zhu H; Koshy M
    Cancer; 2017 Jan; 123(2):273-282. PubMed ID: 27649421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ciliated HPV-related Carcinoma: A Well-differentiated Form of Head and Neck Carcinoma That Can Be Mistaken for a Benign Cyst.
    Bishop JA; Westra WH
    Am J Surg Pathol; 2015 Nov; 39(11):1591-5. PubMed ID: 26457358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Keratinizing-type squamous cell carcinoma of the oropharynx: p16 overexpression is associated with positive high-risk HPV status and improved survival.
    Cai C; Chernock RD; Pittman ME; El-Mofty SK; Thorstad WL; Lewis JS
    Am J Surg Pathol; 2014 Jun; 38(6):809-15. PubMed ID: 24698966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of quantitative (18)F-FDG-PET-CT imaging parameters and human papillomavirus status in oropharyngeal squamous cell carcinoma.
    Schouten CS; Hakim S; Boellaard R; Bloemena E; Doornaert PA; Witte BI; Braakhuis BJ; Brakenhoff RH; Leemans CR; Hoekstra OS; de Bree R
    Head Neck; 2016 Apr; 38(4):529-35. PubMed ID: 25352335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPV-positive head and neck tumours, a distinct clinical entity.
    Nevens D; Nuyts S
    B-ENT; 2015; 11(2):81-7. PubMed ID: 26563006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imbalance Between Clinical and Pathologic Staging in the Updated American Joint Commission on Cancer Staging System for Human Papillomavirus-Positive Oropharyngeal Cancer.
    Fakhry C; Zevallos JP; Eisele DW
    J Clin Oncol; 2018 Jan; 36(3):217-219. PubMed ID: 29161205
    [No Abstract]   [Full Text] [Related]  

  • 16. High-risk human papillomavirus E6/E7 mRNA detection by a novel in situ hybridization assay strongly correlates with p16 expression and patient outcomes in oropharyngeal squamous cell carcinoma.
    Ukpo OC; Flanagan JJ; Ma XJ; Luo Y; Thorstad WL; Lewis JS
    Am J Surg Pathol; 2011 Sep; 35(9):1343-50. PubMed ID: 21836494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population-based p16 and HPV positivity rates in oropharyngeal cancer in Southeast Scotland.
    Wells LA; Junor EJ; Conn B; Pattle S; Cuschieri K
    J Clin Pathol; 2015 Oct; 68(10):849-52. PubMed ID: 26152733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional Outcomes After De-escalated Chemoradiation Therapy for Human Papillomavirus-Positive Oropharyngeal Cancer: Secondary Analysis of a Phase 2 Trial.
    Hegde JV; Shaverdian N; Felix C; Wang PC; Veruttipong D; Hsu S; Riess JW; Rao SD; Daly ME; Chen AM
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):647-651. PubMed ID: 29246721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    An Y; Park HS; Kelly JR; Stahl JM; Yarbrough WG; Burtness BA; Contessa JN; Decker RH; Koshy M; Husain ZA
    Cancer; 2017 Jul; 123(14):2762-2772. PubMed ID: 28323338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of proposed staging systems for human papillomavirus-related oropharyngeal squamous cell carcinoma.
    Malm IJ; Fan CJ; Yin LX; Li DX; Koch WM; Gourin CG; Pitman KT; Richmon JD; Westra WH; Kang H; Quon H; Eisele DW; Fakhry C
    Cancer; 2017 May; 123(10):1768-1777. PubMed ID: 28055120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.